← Back to all articles
Clinical TrialsDOI ResolvedOpen Access

Ayahuasca and Its Main Component N,N-Dimethyltryptamine (DMT) for the Treatment of Mental Disorders: Mechanisms of Action, Clinical Studies, and Tools to Explore the Human Mind

Melani A, Papini G, Bonaso M, Biso L, Kolachalam S, Bragazzi NL, Conversano C, Orrù G, Longoni B, Scarselli M

Biomedicines (2026)

Pharmacokinetic study
Abstract

In recent years, psychopharmacology has experienced a significant challenge, highlighting a renewed and strong scientific interest in psychedelics as breakthrough therapies for mental disorders. Psychedelics can influence cognitive and emotional processes, showing solid therapeutic potential, particularly in treatment-resistant psychiatric disor...

Study TypePharmacokinetic study
dmtayahuascacognitionconsciousness
DOI: 10.3390/biomedicines14030506View on PubMed

Related Articles

Clinical Trials

Registered Clinical Trials of Ayahuasca and DMT: A Scoping Review

Stojanović T, Nilsson KW et al.

Clinical pharmacology and therapeutics, 2026
Depression & Mood

Ayahuasca Therapy: Possible Reduction of Suicidal Ideation in Treatment-Resistant Depression - A Systematic Review

Mano-Sousa BJ, Fontes MCG et al.

Journal of psychoactive drugs, 2026
Neuroscience

Effects of ayahuasca on neuropsychological performance and social cognition: A systematic review

de Paula CC, Vicentini AB et al.

Journal of psychopharmacology (Oxford, England), 2026
Clinical Trials

Acute experiences and persisting psychological effects associated with an encapsulated DMT-harmala alkaloid combination: results of a phase 1 study

Perkins D, Halman A et al.

Scientific Reports, 2025